Patent Grant
11997924
The present invention relates to an organic compound and an organic electroluminescent element comprising the same.
In an organic electroluminescent element, the application of a voltage across two opposite electrodes induces the injection of holes from the anode and electrons from the cathode into an organic layer. The injected holes and electrons recombine with each other to generate excitons which then return to the ground state, emitting light. The materials for use in the organic layer can be classified as luminescent materials, hole injection materials, hole transport materials, electron transport materials, and electron injection materials according to functions.
Widely known are NPB, BCP and Alq3 as materials for hole injection, hole transport and electron transport, and anthracene derivatives and Ir-bearing metal complexes, such as Firpic, Ir(ppy)3, (acac)Ir(btp)2 etc., as luminescent materials.
However, not only are such materials poor in thermal stability due to their low glass transition temperatures, but also organic electroluminescent elements having the materials introduced into organic layers thereof exhibit only an unsatisfactory level of current efficiency and lifespan because the materials are of low triplet energy.
In order to solve the problems encountered in related art, the present invention provides an organic compound that can impart an organic electroluminescent element with an improvement in driving voltage, current efficiency, and lifespan.
Also, the present invention provides an organic electroluminescent element comprising the organic compound.
In order to accomplish the above purposes thereof, the present invention provides a compound represented by the following Formula 1:
wherein,
Ra and Rb may be the same or different from each other and are each independently a C1-C40 alkyl group or a C6-C60 aryl group, or combine with each other to form a fused ring,
R1 to R3 may be the same or different from each other and are each independently selected from the group consisting of a hydrogen, a deuterium, a halogen, a cyano group, a nitro group, an amino group, a C1-C40 alkyl group, a C2-C40 alkenyl group, a C2-C40 alkynyl group, a C3-C40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C6-C60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C1-C40 alkyloxy group, a C6-C60 aryloxy group, a C1-C40 alkylsilyl group, a C6-C60 arylsilyl group, a C1-C40 alkylboron group, a C6-C60 arylboron group, a C1-C40 phosphine group, a C1-C40 phosphine oxide group, and a C6-C60 arylamine group, or provided that adjacent ones of R1 to R3 may combine with each other (in detail, combination between adjacent R1's, between adjacent R2's, between adjacent R3's, or between R1 and R2) to form a fused ring,
L is selected from the group consisting of a single bond, a C6-C18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms,
Z1 to Z5 may be the same or different and are each independently N or C(R4), and provided that Z1 to Z5 include at least one N, and when C(R4) is present in a plural number, they are optionally the same as or different from each other,
c and e are each an integer of 0 to 4,
d is an integer of 0 to 3,
m and n are each an integer of 1 to 3,
R4 is selected from the group consisting of a hydrogen, a deuterium, a halogen, a cyano group, a nitro group, an amino group, a C1-C40 alkyl group, a C2-C40 alkenyl group, a C2-C40 alkynyl group, a C3-C40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C6-C60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C1-C40 alkyloxy group, a C6-C60 aryloxy group, a C1-C40 alkylsilyl group, a C6-C60 arylsilyl group, a C1-C40 alkylboron group, a C6-C60 arylboron group, a C1-C40 phosphine group, a C1-C40 phosphine oxide group, and a C6-C60 arylamine group, or bonded to an adjacent substituent (in detail, adjacent R4's are bonded to each other) to form a fused ring,
the alkyl and aryl groups of Ra and Rb; the alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, alkyloxy, aryloxy, alkylsilyl, arylsilyl, alkylboron, arylboron, phosphine, phosphine oxide, and arylamine groups of R1 to R4; and the arylene and heteroarylene groups of L may be optionally each independently unsubstituted or substituted with at least one selected from the group consisting of a deuterium, a halogen, a cyano group, a nitro group, an amino group, a C1-C40 alkyl group, a C2-C40 alkenyl group, a C2-C40 alkynyl group, a C3-C40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C6-C60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C1-C40 alkyloxy group, a C6-C60 aryloxy group, a C1-C40 alkylsilyl group, a C6-C60 arylsilyl group, a C1-C40 alkylboron group, a C6-C60 arylboron group, a C1-C40 phosphine group, a C1-C40 phosphine oxide group, and a C6-C60 arylamine group, and provided that when the substituent is present in a plural number, they are optionally the same or different from each other.
In addition, the present invention provides an organic electroluminescent element comprising an anode, a cathode, and at least one organic layer interposed therebetween, wherein at least one of the organic layer comprises the compound represented by Formula 1.
Having excellent thermal stability and emitting properties, the compound, represented by Formula 1, of the present invention can be available for use in an organic layer of an organic electroluminescent element. Particularly when used as a material for a light-emitting layer or an auxiliary electron transport layer, the compound, represented by Formula 1, of the present invention can impart excellent emission performance, low driving voltage, high efficiency and long lifespan to the organic electroluminescent element, thereby allowing for the fabrication of a full-color display panel improved in performance and lifespan.
Below, a detailed description is given of the present invention.
1. Organic Compound
The organic compound of the present invention has a framework, represented by Formula 1, in which a fluorene moiety is bonded to a 6-membered heterocyclic ring through a linker (phenylene, biphenylene or terphenylene).
The fluorene moiety serves as an electron donor group (EDG) with high electron donating ability. When the fluorene moiety is connected via a linker to a 6-membered heterocyclic ring that serves as an electron withdrawing group (EWG) with high electron withdrawing ability (e.g., pyridine, pyrimidine, triazine, etc.), the overall molecule exhibits a bipolar property. Accordingly, the compound of the present invention can improve hole-electron recombination.
In addition, since the linker, e.g., phenylene, or biphenylene or terphenylene, functions to minimize interaction between the electron donor group and the electron withdrawing group, the compound of the present invention into which the linker is introduced has a wide bandgap and a high triplet energy. Hence, the compound of the present invention, if applied to an organic layer, minimizes the diffusion of excitons to adjacent other organic layers. An organic electroluminescent element comprising such an organic layer can be improved in light emission efficiency and lifespan, compared to that comprising an organic layer lacking the linker. Further, with the introduction of a linker thereto, the compound of the present invention has a higher molecular weight than those lacking the linker, thus improving in thermal stability.
Such effects may be more intensified when bonds between an electron donor group and a linker, between linkers, and between a linker and an electron drawing group are more twisted structure formed thereof.
The compound, represented by Formula 1, of the present invention may be embodied by one of the compounds represented by the following Formulas 2 to 4:
wherein,
Ra, Rb, R1 to R3, Z1 to Z5, c, d, and e are the same as defined in Formula 1.
In the compound represented by Formula 1 of the present invention, the structure (substituent) represented by
(* is a site where to bond with L) is particularly embodied by one of the structures (substituents) represented by the following C-1 to C-15.
wherein,
R4 is the same as defined in Formula 1 and a plurality of R4's are the same or different,
R5 is selected from the group consisting of a hydrogen, a deuterium, a halogen, a cyano group, a nitro group, a C1-C40 alkyl group, a C2-C40 alkenyl group, a C2-C40 alkynyl group, a C3-C40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C6-C60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C6-C60 aryloxy group, a C1-C40 alkyloxy group, a C6-C60 arylamine group, a C1-C40 alkylsilyl group, a C1-C40 alkylboron group, a C6-C60 arylboron group, a C6-C60 arylphosphine group, a C6-C60 arylphosphine oxide group, and a C6-C60 arylsilyl group, or combines with an adjacent substituent (in detail, combination between adjacent R5's or between R4 and R5) to form a fused ring,
p is an integer of 1 to 4,
the alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, aryl, heteroaryl, aryloxy, alkyloxy, arylamine, alkylsilyl, alkylboron, arylboron, arylphosphine, arylphosphine oxide and arylsilyl groups of R5 may be each independently unsubstituted or substituted with at least one selected from the group consisting of a deuterium, a halogen, a cyano group, a nitro group, a C1-C40 alkyl group, a C2-C40 alkenyl group, a C2-C40 alkynyl group, a C6-C60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C6-C60 aryloxy group, a C1-C40 alkyloxy group, a C6-C60 arylamine group, a C3-C40 cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C1-C40 alkylsilyl group, a C1-C40 alkylboron group, a C6-C60 arylboron group, a C6-C60 arylphosphine group, a C6-C60 arylphosphine oxide group, and a C6-C60 arylsilyl group, and provided that when the substituent is present in a plural number, they are optionally the same or different from each other.
Here, the structure represented by
is more particularly the structure represented by C-4, C-6, or C-9. In greater detail, the compound, represented by Formula 1, of the present invention may be those represented by the following Formulas 5 to 7:
wherein,
Ra, Rb, R1 to R4, L, c, d, e, m, and n are the same as defined in Formula 1, respectively. Here, considering properties of organic electroluminescent device, it is preferred that R4's in the compound represented by Formula 5 are the same. That is, identical R4's particularly give a symmetrical structure to the compound. In the compounds represented by Formulas 6 and 7, it is preferred that at least two of the plural R4's are different from each other.
When account is taken of properties of organic electroluminescent device, it is preferred that Ra and Rb in the compound represented Formula 1 of the present invention are each independently a methyl or a phenyl, or bond each other to form a fused ring represented by
(* is a site where to bond).
In the compound represented by Formula 1, R1 to R3 are each independently selected from the group consisting of hydrogen, deuterium, a C1-C40 alkyl group, a C6-C60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, and a C6-C60 arylamine group. In addition, m and n are each an integer of 1 to 3, and preferably m is 1 and n is 1 or 2.
In the compound represented by Formula 1 of the present invention, L may be preferably a single bond, phenylene, or biphenylene. In detail, the linker L is preferably selected from the group consisting of the structures represented by the following L-1 to L-7 (* is a site where to bond), more preferably the structure represented by L-6.
When the linker L is the structure represented by L-6, the compound, represented by Formula 1, of the present invention may be embodied by the compound represented by the following Formula 8:
wherein,
Ra, Rb, R1, R2, R4, Z3, c, and d are the same as defined in Formula 1, respectively.
In greater detail, the compound, represented by Formula 1, of the present invention may be further embodied by the compounds represented by the following Formulas 9 to 12:
Concrete examples of the compound, represented by Formula 1, of the present invention include, but are not limited to, the following Compounds 1 to 366:
As used herein, the term “alkyl” refers to a monovalent substituent derived from linear or branched saturated hydrocarbon of 1 to 40 carbon atoms, including, for example, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl, and the like.
As used herein, the term “alkenyl” refers to a monovalent substituent derived from a linear or branched unsaturated hydrocarbon with one more carbon-carbon double bonds, as exemplified by vinyl, allyl, isopropenyl, 2-butenyl, and the like.
As used herein, the term “alkynyl” refers to a monovalent substituent derived from a linear or branched unsaturated hydrocarbon of 2 to 40 carbon atoms with at least one carbon-carbon triple bond, as exemplified by ethynyl, 2-propynyl, and the like.
As used herein, the term “aryl” denotes a monovalent substituent derived from an aromatic hydrocarbon of 6 to 60 carbon atoms with a single ring or a combination of two or more rings in which two or more rings may simply be pendant to each other or fused together, as exemplified by phenyl, naphthyl, phenantryl, anthryl, etc.
As used herein, the term “heteroaryl” denotes a monovalent substituent derived from a mono- or polyheterocyclic aromatic hydrocarbon of 5 to 60 nuclear atoms in which at least one, particularly one to three carbon atoms of the ring are substituted by a heteroatom such as N, O, S or Se. Two or more rings of the heteroaryl, if present, may simply be pendant to each other or fused together or to an aryl group. Examples include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl, polycyclic rings such as phenoxathienyl, indolizinyl, indolyl, purinyl, quinolyl, benzothiazole, and carbazolyl, 2-furanyl, N-imidazolyl, 2-ixosazolyl, 2-pyridinyl, and 2-pyrimidinyl.
As used herein, the term “aryloxy” refers to a monovalent substituent represented by RO— wherein R denotes an aryl of 6 to 60 carbon atoms, as exemplified by phenyloxy, naphthyloxy, diphenyloxy, etc.
As used herein, the term “alkyloxy” refers to a monovalant substituent represented by R′O— wherein R′ means an alkyl of 1 to 40 carbon atoms and is construed to include a linear, branched or cyclic structure and examples of which include methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy, etc.
As used herein, the term “arylamine” refers to an amine substituted with an aryl of 6 to 60 carbon atoms.
As used herein, the term “cycloalkyl” refers to a monovalent substituent derived from a mono- or polycyclic non-aromatic hydrocarbon of 3 to 40 carbon atoms, examples of which include cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, and adamantine.
As used herein, the term “heterocycloalkyl” refers to a monovalent substituent derived from a non-aromatic hydrocarbon of 3 to 40 nuclear atoms in which at least one, particularly one to three carbon atoms of the ring are substituted by a heteroatom such as N, O, S or Se and examples of which include morpholinem, piperazine, and the like.
As used herein, the term “alkylsilyl” refers to a silyl substituent substituted with an alkyl of 1 to 40 carbon atoms, and the term “arylsilyl” refers to a silyl group substituted with an aryl of 6 to 60 carbon atoms.
As used herein, the term “fused ring” refers to a fused aliphatic ring, a fused aromatic ring, a fused heteroaliphatic ring, a heteroaromatic ring, or a combination thereof.
2. Organic Electroluminescent Element
The present invention provides an organic electroluminescent element comprising the compound represented by Formula 1.
In detail, the organic electroluminescent element of the present invention comprises an anode, a cathode, and at least one organic layer interposed therebetween wherein the at least one organic layer comprises the compound represented by Formula 1. Here, the compound may be a single kind or a combination of two or more different kinds.
The at least one organic layer may be selected from among a hole injection layer, a hole transport layer, an auxiliary light-emitting layer, an electron transport layer, an electron injection layer, and a combination thereof, and may comprise the compound represented by Formula 1. In detail, the organic layer comprising the compound represented by Formula 1 is particularly a light-emitting layer or an auxiliary electron transport layer (interposed between a light-emitting layer and an electron transport layer).
Meanwhile, the light-emitting layer may comprise a host. Here, the host may be the compound represented by Formula 1, alone or in combination with other compounds. In addition, the light-emitting layer may comprise a dopant based on a metal complex compound, together with the host.
No particular limitations are imparted to the structure of the organic electroluminescent element of the present invention. For example, the organic electroluminescent element may have a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, an auxiliary light-emitting layer, a light-emitting layer, an auxiliary electron transport layer, an electron transport layer, and a cathode are sequentially deposited. Here, an electron injection layer may be further deposited on the electron transport layer. Moreover, an insulation layer or an adhesive layer may be introduced into the interface between the electrode (cathode or anode) and the organic layer.
The organic electroluminescent element of the present invention can be fabricated using materials and methods known in the art, with the exception that at least one of the organic layers comprises the compound represented by Formula 1.
The organic layer may be formed using a vacuum deposition method or a solution coating method. Examples of the solution coating method include spin coating, dip coating, doctor blade coating, inkjet printing and a thermal transfer method, but are not limited thereto.
The substrate used for the fabrication of the organic electroluminescent element of the present invention is not particularly limited, and may be a silicon wafer, quartz, a glass plate, a metal plate, or a plastic film.
As for the anode, its material is not particularly limited, but may be a metal such as vanadium, chromium, copper, zinc, gold, etc., or an alloy thereof; a metal oxide such as zinc oxide, indium oxide, indium tin oxide(ITO), and indium zinc oxide(IZO); a combination of metal and oxide such as ZnO:Al or SnO2:Sb; a conductive polymer such as polythiophene, poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDT), polypyrrole or polyaniline; and carbon black.
Although no particular limitations are imparted thereto, a material available for the cathode may be a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin and lead, or an alloy thereof; or a multilayer material such as LiF/Al or LiO2/A.l.
In addition, the hole injection layer, the hole transport layer, the electron injection layer and the electron transport layer are not particularly limited, and may be made of conventional materials known in the art.
The present invention will be in greater detail described through the following examples that are set forth to illustrate, but are not to be construed as limiting the present invention.
Under a nitrogen stream, 2-(3-bromophenyl)-4,6-diphenyl-[1,3,5]triazine (10.0 g, 0.026 mol), 9,9-dimethyl-9H-fluoren-2-yl-boronic acid (7.9 g, 0.033 mol), Pd(PPh3)4 (0.95 g, 0.001 mol), and potassium carbonate (7.65 g, 0.078 mol) were mixed and then stirred under reflux with 1,4-dioxane (80 ml) and H2O (20 ml). After completion of the reaction, an organic layer was separated with methylene chloride, and dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Compound 1 (8.2 g, yield 63%).
HRMS [M]+: 501.62
The same procedure was conducted as in Synthesis Example 1, with the exception of using 9,9-dimethyl-9H-fluoren-3-yl-boronic acid (7.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, to afford Compound 3.
HRMS [M]+: 501.62
The same procedure was conducted as in Synthesis Example 1, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, to afford Compound 69.
HRMS [M]+: 625.76
The same procedure was conducted as in Synthesis Example 1, with the exception of using 9,9′-spirobi[9H-fluorene]-2-yl-boronic acid (11.88 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, to afford Compound 129.
HRMS [M]+: 623.74
The same procedure was conducted as in Synthesis Example 1, with the exception of using 4-(3-bromophenyl)-2,6-diphenyl-pyrimidine (10.0 g, 0.026 mol) instead of 2-(3-bromophenyl)-4,6-diphenyl-[1,3,5]triazine, to afford Compound 6.
HRMS [M]+: 500.63
The same procedure was conducted as in Synthesis Example 5, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, to afford Compound 74.
HRMS [M]+: 624.77
The same procedure was conducted as in Synthesis Example 5, with the exception of using 9,9′-spirobi[9H-fluorene]-2-yl-boronic acid (12.77 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, to afford Compound 134.
HRMS [M]+: 622.75
The same procedure was conducted as in Synthesis Example 1, with the exception of using 4-(3-bromophenyl)-2,6-diphenyl-pyridine (10.0 g, 0.026 mol) instead of 2-(3-bromophenyl)-4,6-diphenyl-[1,3,5]triazine, to afford Compound 7.
HRMS [M]+: 499.64
The same procedure was conducted as in Synthesis Example 8, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, to afford Compound 75.
HRMS [M]+: 623.78
The same procedure was conducted as in Synthesis Example 8, with the exception of using 9,9′-spirobi[9H-fluorene]-2-yl-boronic acid (12.77 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, to afford Compound 135.
HRMS [M]+: 622.71
Under a nitrogen stream, 2-(3-bromophenyl)-4,6-diphenyl-[1,3,5]triazine (12.0 g, 0.031 mol), 3-chlorophenylboronic acid (6.3 g, 0.040 mol), Pd(PPh3)4 (1.15 g, 0.001 mol), and potassium carbonate (12.85 g, 0.093 mol) were mixed and then stirred under reflux with 1,4-dioxane (100 ml) and H2O (25 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Intermediate 1-A (11.0 g, yield 83%).
Under a nitrogen stream, Intermediate 1-A (11.0 g, 0.026 mol) obtained in Step 1, 9,9-dimethyl-9H-fluoren-2-yl-boronic acid (7.9 g, 0.033 mol), Pd (OAc)2 (0.29 g, 0.001 mol), cesium carbonate (25.4 g, 0.078 mol), and Xphos (1.23 g, 0.003 mol) were mixed and then stirred under reflux with toluene (100 ml)/ethanol (20 ml)/H2O (20 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Compound 21 (8.2 g, yield 63%).
HRMS [M]+: 577.72
The same procedure was conducted as in Synthesis Example 11, with the exception of using 9,9-dimethyl-9H-fluoren-3-yl-boronic acid (7.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 11, to afford Compound 23.
HRMS [M]+: 577.72
The same procedure was conducted as in Synthesis Example 11, with the exception of using (9,9-dimethyl-9H-fluoren-2-yl)-boronic acid (7.9 g, 0.033 mol) instead of 9,9-Dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 11.
HRMS [M]+: 701.85
The same procedure was conducted as in Synthesis Example 11, with the exception of using (9,9-diphenyl-9H-fluoren-3-yl)boronic acid (7.9 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-2-yl)boronic acid used in Step 2 of Synthesis Example 11, to afford Compound 91.
HRMS [M]+: 701.85
The same procedure was conducted as in Synthesis Example 11, with the exception of using 9,9′-Spirobi[9H-fluorene]-2-yl-boronic acid (12.77 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 11, to afford Compound 149.
HRMS [M]+: 699.84
The same procedure was conducted as in Synthesis Example 11, with the exception of using 9,9′-spirobi[fluoren]-3-yl-boronic acid (12.77 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 11, to afford Compound 151.
HRMS [M]+: 699.84
The same procedure was conducted as in Step 1 of Synthesis Example 11, with the exception of using 4-(3-bromophenyl)-2,6-diphenyl-pyrimidine (12.0 g, 0.031 mol) instead of 2-(3-bromophenyl)-4,6-diphenyl-[1,3,5]triazine used in Step 1 of Synthesis Example 11, to afford Intermediate 2-A.
The same procedure was conducted as in Step 2 of Synthesis Example 11, with the exception of using Intermediate 2-A (11.0 g, 0.026 mol) synthesized in Step 1 instead of Intermediate 1-A used in Step 2 of Synthesis Example 11, to afford Compound 31.
HRMS [M]+: 576.73
The same procedure was conducted as in Synthesis Example 17, with the exception of using 9,9-dimethyl-9H-fluoren-3-yl-boronic acid (7.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 17, to afford Compound 35.
HRMS [M]+: 576.73
The same procedure was conducted as in Synthesis Example 17, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 17, to afford Compound 99.
HRMS [M]+: 687.85
The same procedure was conducted as in Synthesis Example 17, with the exception of using 9,9′-spirobi[9H-fluorene]-2-yl-boronic acid (11.88 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 17, to afford Compound 159.
HRMS [M]+: 698.85
The same procedure was conducted as in Step 1 of Synthesis Example 11, with the exception of using 4-(3-bromophenyl)-2,6-diphenyl-pyridine (12.0 g, 0.031 mol) instead of 2-(3-bromophenyl)-4,6-diphenyl-[1,3,5]triazine used in Step 1 of Synthesis Example 11, to afford Intermediate 3-A.
The same procedure was conducted as in Step 2 of Synthesis Example 11, with the exception of using Intermediate 3-A (11.0 g, 0.026 mol) synthesized in Step 1 instead of Intermediate 1-A used in Step 2 of Synthesis Example 11, to afford Compound 45.
The same procedure was conducted as in Synthesis Example 21, with the exception of using 9,9-dimethyl-9H-fluoren-3-yl-boronic acid (7.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 21, to afford Compound 53.
HRMS [M]+: 501.62
The same procedure was conducted as in Synthesis Example 21, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-Dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 21, to afford Compound 113.
HRMS [M]+: 699.88
The same procedure was conducted as in Synthesis Example 21, with the exception of using 9,9′-spirobi[9H-fluorene]-2-yl-boronic acid (11.88 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 21, to afford Compound 173.
HRMS [M]+: 697.86
Under a nitrogen stream, Intermediate 1-A (11.0 g, 0.026 mol), 3-Chlorophenylboronic acid (4.8 g, 0.031 mol), Pd(OAc)2 (0.29 g, 0.001 mol), Cesium carbonate (25.4 g, 0.078 mol), and Xphos (0.3 g, 0.003 mol) were mixed and then stirred under reflux with toluene (100 ml)/ethanol (20 ml)/H2O (20 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Intermediate 1-B (7.5 g, yield 58%).
Under a nitrogen stream, Intermediate 1-B (7.5 g, 0.015 mol) obtained in Step 1, 9,9-dimethyl-9H-fluoren-2-yl-boronic acid (4.3 g, 0.018 mol), Pd(OAc)2 (0.17 g, 0.75 mmol), cesium carbonate (14.6 g, 0.045 mol), and Xphos (0.7 g, 1.5 mmol) were mixed and stirred under reflux with toluene (60 ml)/ethanol (15 ml)/H2O (15 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=4:1 (v/v)] to afford Compound 61 (8.1 g, yield 83%).
HRMS [M]+: 653.83
The same procedure was conducted as in Synthesis Example 25, with the exception of using (9,9-dimethyl-9H-fluoren-3-yl)boronic acid (4.3 g, 0.018 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 25, to afford Compound 62.
HRMS [M]+: 653.83
Under a nitrogen stream, Intermediate 2-A (11.0 g, 0.026 mol), 3-chlorophenylboronic acid (4.8 g, 0.031 mol), Pd(OAc)2 (0.29 g, 0.001 mol), Cesium carbonate (25.4 g, 0.078 mol), and Xphos (0.3 g, 0.003 mol) were mixed and then stirred under reflux with toluene (100 ml)/ethanol (20 ml)/H2O (20 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Intermediate 2-B (7.5 g, yield 58%).
Under a nitrogen stream, Intermediate 2-B (7.5 g, 0.015 mol), 9,9-dimethyl-9H-fluoren-2-yl-boronic acid (4.3 g, 0.018 mol) obtained in Step 1, Pd(OAc)2 (0.17 g, 0.75 mmol), cesium carbonate (14.6 g, 0.045 mol), and Xphos (0.7 g, 1.5 mmol) were mixed and then mixed and then stirred under reflux with toluene (60 ml)/Ethanol (15 ml)/H2O (15 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=4:1 (v/v)] to afford Compound 63 (8.1 g, yield 83%).
HRMS [M]+: 652.84
The same procedure was conducted as in Synthesis Example 27, with the exception of using (9,9-dimethyl-9H-fluoren-3-yl)boronic acid (4.3 g, 0.018 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 27, to afford Compound 64.
HRMS [M]+: 652.84
The same procedure was conducted as in Step 1 of Synthesis Example 11, with the exception of using 2-([1,1′-biphenyl]-4-yl)-4-(3-bromophenyl)-6-phenyl-1,3,5-triazine (14.4 g, 0.031 mol) instead of 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine used in Step 1 of Synthesis Example 11, to afford Intermediate 4-A.
The same procedure was conducted as in Step 2 of Synthesis Example 11, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 11, to afford Compound 200.
HRMS [M]+: 777.97
The same procedure was conducted as in Step 1 of Synthesis Example 11, with the exception of using 4-([1,1′-biphenyl]-4-yl)-6-(3-bromophenyl)-2-phenylpyrimidine (14.3 g, 0.031 mol) instead of 2-(3-bromophenyl)-4,6-diphenyl-1,3,5-triazine used in Step 1 of Synthesis Example 11, to afford Intermediate 5-A.
The same procedure was conducted as in Step 2 of Synthesis Example 11, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 11, to afford Compound 206.
HRMS [M]+: 776.98
Under a nitrogen stream, 2-(3-Bromo-phenyl)-4,6-diphenyl-[1,3,5]triazine (12.0 g, 0.031 mol), 3-Chlorophenylboronic acid (6.3 g, 0.040 mol), Pd(PPh3)4 (1.15 g, 0.001 mol) and potassium carbonate (12.85 g, 0.093 mol) were mixed and then stirred under reflux with, 1,4-dioxane (100 ml) and H2O (25 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Intermediate I-1 (11.0 g, yield 83%).
Under a nitrogen stream, Intermediate I-1 (11.0 g, 0.026 mol) obtained in Step 1, (9,9-dimethyl-9H-fluoren-1-yl)boronic acid (7.9 g, 0.033 mol), Pd(OAc)2 (0.29 g, 0.001 mol), Cesium carbonate (25.4 g, 0.078 mol), and Xphos (1.23 g, 0.003 mol) were mixed and then stirred under reflux with toluene (100 ml), ethanol (20 ml) and H2O (20 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Compound 217 (8.2 g, yield 63%).
HRMS [M]+: 577.25
The same procedure was conducted as in Synthesis Example 31, with the exception of using (9,9-diphenyl-9H-fluoren-1-yl)boronic acid (12.0 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 218.
HRMS [M]+: 701.28
The same procedure was conducted as in Synthesis Example 31, with the exception of using (9,9′-spirobi[fluoren]-1-yl)boronic acid (11.9 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 220.
HRMS [M]+: 699.27
The same procedure was conducted as in Synthesis Example 31, with the exception of using (9,9-dimethyl-9H-fluoren-2-yl)boronic acid (7.9, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 21.
HRMS [M]+: 577.25
The same procedure was conducted as in Synthesis Example 31, with the exception of using (9-methyl-9-phenyl-9H-fluoren-2-yl)boronic acid (9.9, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 189.
HRMS [M]+: 639.27
The same procedure was conducted as in Synthesis Example 31, with the exception of using (7,7-dimethyl-7H-benzo[c]fluoren-9-yl)boronic acid (9.5, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 193.
HRMS [M]+: 627.27
The same procedure was conducted as in Synthesis Example 31, with the exception of using (9,9-dimethyl-7-phenyl-9H-fluoren-2-yl)boronic acid (10.4 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1l-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 65.
HRMS [M]+: 653.28
The same procedure was conducted as in Synthesis Example 31, with the exception of using (spiro[benzo[c]fluorene-7,9′-fluoren]-9-yl)boronic acid (13.5 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 231.
HRMS [M]+: 749.28
The same procedure was conducted as in Synthesis Example 31, with the exception of using (13,13-dimethyl-13H-indeno[1,2-1]phenanthren-11-yl) boronic acid (11.2 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 234.
HRMS [M]+: 677.28
The same procedure was conducted as in Synthesis Example 31, with the exception of using (9,9-di-p-tolyl-9H-fluoren-4)-yl)boronic acid (12.9 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 250.
HRMS [M]+: 729.31
The same procedure was conducted as in Synthesis Example 31, with the exception of using (4′-phenyl-9,9′-spirobi[fluoren]-4-yl)boronic acid (14.4 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-1-yl)boronic acid used in Step 2 of Synthesis Example 31, to afford Compound 252.
HRMS [M]+: 775.30
Under a nitrogen stream, 2-(3-bromophenyl)-4,6-diphenylpyrimidine (10.0 g, 0.026 mol), 9,9-dimethyl-9H-fluoren-2-yl-boronic acid (7.9 g, 0.033 mol), Pd(PPh3)4 (0.95 g, 0.001 mol), and potassium carbonate (7.65 g, 0.078 mol) were mixed and then stirred under reflux with 1,4-dioxane (80 ml) and H2O (20 ml). After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Compound 5 (8.5 g, yield 66%).
HRMS [M]+: 500.23
The same procedure was conducted as in Synthesis Example 42, with the exception of using 9,9-dimethyl-9H-fluoren-3-yl-boronic acid (7.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, to afford Compound 13.
HRMS [M]+: 500.23
The same procedure was conducted as in Synthesis Example 42, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid to afford Compound 73.
HRMS [M]+: 624.26
The same procedure was conducted as in Synthesis Example 42, with the exception of using 9,9′-Spirobi[9H-fluorene]-2-yl-boronic acid (11.88 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid to afford Compound 133.
HRMS [M]+: 622.24
The same procedure was conducted as in Synthesis Example 42, with the exception of using 4-(3-bromophenyl)-2,6-diphenylpyrimidine (10.0 g, 0.026 mol) and 9,9′-Spirobi[9H-fluorene]-2-yl-boronic acid (12.77 g, 0.033 mol) instead of 2-(3-bromophenyl)-4,6-diphenylpyrimidine and 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, respectively, to afford Compound 134.
HRMS [M]+: 622.24
Under a nitrogen stream, 2-(3-bromophenyl)-4,6-diphenylpyrimidine (12.0 g, 0.031 mol), 3-chlorophenylboronic acid (6.3 g, 0.040 ol), Pd(PPh3)4 (1.15 g, 0.001 mol), and potassium carbonate (12.85 g, 0.093 mol) were mixed and then stirred under reflux with 1,4-dioxane (100 ml) and H2O (25 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Intermediate 1-A (11.0 g, yield 83%).
Under a nitrogen stream, Intermediate 1-A (11.0 g, 0.026 mol) obtained in Step 1, 9,9-dimethyl-9H-fluoren-2-yl-boronic acid (7.9 g, 0.033 mol), Pd(OAc)2 (0.29 g, 0.001 mol), Cesium carbonate (25.4 g, 0.078 mol), and Xphos (1.23 g, 0.003 mol) were mixed and then stirred under reflux with toluene (100 ml), ethanol (20 ml), and H2O (20 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Compound 29 (11.2 g, yield 74%).
HRMS [M]+: 576.26
The same procedure was conducted as in Synthesis Example 47, with the exception of using 9,9-dimethyl-9H-fluoren-3-yl-boronic acid (7.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 47 to afford Compound 33.
HRMS [M]+: 576.26
The same procedure was conducted as in Synthesis Example 47, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (12.0 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 47 to afford Compound 97.
HRMS [M]+: 700.29
The same procedure was conducted as in Synthesis Example 47, with the exception of using (9,9-diphenyl-9H-fluoren-3-yl)boronic acid (12.0 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-2-yl)boronic acid used in Step 2 of Synthesis Example 47 to afford Compound 101.
HRMS [M]+: 700.29
The same procedure was conducted as in Synthesis Example 47, with the exception of using 9,9′-Spirobi[9H-fluorene]-2-yl-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 47 to afford Compound 157.
HRMS [M]+: 698.27
The same procedure was conducted as in Synthesis Example 47, with the exception of using 9,9′-spirobi[fluoren]-3-yl-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 47 to afford Compound 161.
HRMS [M]+: 698.27
The same procedure was conducted as in Step 1 of Synthesis Example 47, with the exception of using 4-(3-bromophenyl)-2,6-diphenylpyrimidine (12.0 g, 0.031 mol) instead of 2-(3-bromophenyl)-4,6-diphenylpyrimidine used in Step 1 of Synthesis Example 47 to afford Intermediate 2-A.
The same procedure was conducted as in Step 2 of Synthesis Example 47, with the exception of using Intermediate 2-A (11.0 g, 0.026 mol) synthesized in Step 1 and (9,9-dimethyl-9H-fluoren-4-yl)boronic acid (7.9 g, 0.033 mol) instead of Intermediate 1-A used in Step 2 of Synthesis Example 47 and 9,9-dimethyl-9H-fluoren-2-yl-boronic acid, respectively, to afford Compound 282.
HRMS [M]+: 576.26
The same procedure was conducted as in Synthesis Example 53, with the exception of using 9,9′-spirobi[9H-fluorene]-2-yl-boronic acid (11.9 g, 0.033 mol) instead of (9,9-dimethyl-9H-fluoren-4-yl)boronic acid used in Step 2 of Synthesis Example 53 to afford Compound 159.
HRMS [M]+: 698.27
The same procedure was conducted as in Step 1 of Synthesis Example 53, with the exception of using 4-([1,1′-biphenyl]-4-yl)-6-(3-bromophenyl)-2-phenyl-pyrimidine (14.4 g, 0.031 mol) instead of 4-(3-bromo-phenyl)-2,6-diphenyl-pyrimidine used in Step 1 of Synthesis Example 53 to afford Intermediate 3-A.
The same procedure was conducted as in Step 2 of Synthesis Example 53, with the exception of using Intermediate 3-A (12.9 g, 0.026 mol) synthesized in Step 1 and (9,9-dimethyl-9H-fluoren-2-yl)boronic acid instead of Intermediate 2-A used in Step 2 of Synthesis Example 53 and (9,9-dimethyl-9H-fluoren-4-yl)boronic acid, respectively, to afford Compound 205.
HRMS [M]+: 652.29
The same procedure was conducted as in Synthesis Example 55, with the exception of using (9,9-diphenyl-9H-fluoren-2-yl)-boronic acid (11.9 g, 0.033 mol) instead of 9,9-dimethyl-9H-fluoren-2-yl-boronic acid used in Step 2 of Synthesis Example 55, to afford Compound 206.
HRMS [M]+: 776.32
Under a nitrogen stream, Intermediate 1-A (11.0 g, 0.026 mol), 3-chlorophenylboronic acid (4.8 g, 0.031 mol), Pd(OAc)2 (0.29 g, 0.001 mol), Cesium carbonate (25.4 g, 0.078 mol), and Xphos (0.3 g, 0.003 mol) were mixed and then stirred under reflux with toluene (100 ml), ethanol (20 ml) and H2O (20 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=5:1 (v/v)] to afford Intermediate 1-B (7.5 g, yield 58%).
Under a nitrogen stream, Intermediate 1-B (7.5 g, 0.015 mol) synthesized in Step 1, 9,9-dimethyl-9H-fluoren-3-yl-boronic acid (4.3 g, 0.018 mol), Pd(OAc)2 (0.17 g, 0.75 mmol), Cesium carbonate (14.6 g, 0.045 mol), and Xphos (0.7 g, 1.5 mmol) were mixed and then stirred under reflux with toluene (60 ml), ethanol (15 ml) and H2O (15 ml).
After completion of the reaction, an organic layer was separated with methylene chloride and then dried over MgSO4. The solvent was removed from the dehydrated organic layer, followed by purification through column chromatography [hexane:MC=4:1 (v/v)] to afford Compound 336 (8.1 g, yield 83%).
HRMS [M]+: 652.29
The compounds synthesized in the Synthesis Examples were purified by sublimation to a high degree of purity using a conventional method known in the art before being applied to the fabrication of green organic electroluminescent elements as follows.
First, a glass substrate coated with an ITO (indium tin oxide) thin film 1500 Å thick was cleansed by ultrasonication in distilled water and then in a solvent such as isopropyl alcohol, acetone, methanol, etc. and then dried. The glass substrate was transferred to a UV OZONE cleaner (Power sonic 405, Hwashin Tech) and cleaned for 5 min using UV, and transferred to a vacuum evaporator.
On the transparent ITO substrate (electrode) thus obtained, m-MTDATA (60 nm)/TCTA (80 nm)/90% of each of the compounds synthesized in Synthesis Examples 1 to 41+10% of Ir(ppy)3 (30 nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) were deposited in that order to fabricate organic electroluminescent elements.
Structures of m-MTDATA, TCTA, Ir(ppy)3 and BCP are as follows.
A green organic electroluminescent element was fabricated in the same manner as in Example 1, with the exception of using the following CBP instead of Compound 1 synthesized in Synthesis Example 1.
A green organic electroluminescent element was fabricated in the same manner as in Example 1, with the exception of using the following Compound A instead of Compound 1 synthesized in Synthesis Example 1.
A green organic electroluminescent element was fabricated in the same manner as in Example 1, with the exception of using the following Compound B instead of Compound 1 synthesized in Synthesis Example 1.
The green organic electroluminescent elements fabricated in Examples 1 to 41 and Comparative Examples 1 to 3 were measured for driving voltage at a current density of 10 mA/cm2, current efficiency, and emitting peak, and the results are summarized in Table 1, below.
As understood from Table 1, the organic electroluminescent elements employing the compounds of the present invention in the light-emitting layer thereof (Examples 1 to 41) are far superior in terms of current efficiency and driving voltage compared to that employing the conventional material CBP in the light-emitting layer thereof (Comparative Example 1).
In addition, when used in the light-emitting layer of an organic electroluminescent element, the compounds having the linker (Examples 1 to 41) decrease the driving voltage and increases current efficiency in the organic electroluminescent element, compared to those lacking the linker (Comparative Examples 2 and 3).
The compounds synthesized in the Synthesis Examples were purified by sublimation to a high degree of purity using a conventional method known in the art before being applied to the fabrication of blue organic electroluminescent elements having the structures listed in Table 2, below.
The structures of NPB, ADN, and Alq3 listed in Table 2 are as follows.
A blue organic electroluminescent element was fabricated in the same manner as in Example 42, with the exception that an electron transport layer 30 nm thick was deposited without using an auxiliary electron transport layer.
A blue organic electroluminescent element was fabricated in the same manner as in Example 42, with the exception of using the following BCP instead of Compound 1 synthesized in Synthesis Example 1.
The blue organic electroluminescent elements fabricated in Examples 42 to 98 and Comparative Examples 4 and 5 were measured for driving voltage at a current density of 10 mA/cm2, current efficiency, and emitting peak, and the results are summarized in Table 3, below.
As shown in Table 3, the compounds according to the present invention, when used in auxiliary electron transport layer of blue organic electroluminescent elements (Examples 42 to 98), impart excellent current efficiency and driving voltages to the blue organic electroluminescent elements.
| Number | Date | Country | Kind |
|---|---|---|---|
| 10-2014-0188953 | Dec 2014 | KR | national |
| 10-2015-0171639 | Dec 2015 | KR | national |
| 10-2015-0171678 | Dec 2015 | KR | national |
| 10-2015-0178926 | Dec 2015 | KR | national |
This application is a Continuation of U.S. application Ser. No. 15/539,223 filed Jun. 23, 2017, which is National Stage of International Application No. PCT/KR2015/014222 filed Dec. 24, 2015, claiming priorities based on Korean Patent Application Nos. 10-2014-0188953, filed Dec. 24, 2014, 10-2015-0171639, filed Dec. 3, 2015, 10-2015-0171678, filed Dec. 3, 2015, and 10-2015-0178926, filed Dec. 15, 2015, the contents of all of which are incorporated herein by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 9120773 | Aihara et al. | Sep 2015 | B2 |
| 9209406 | Mizutani et al. | Dec 2015 | B2 |
| 9266851 | Yoshida et al. | Feb 2016 | B2 |
| 9624193 | Aihara et al. | Apr 2017 | B2 |
| 9640766 | Jang et al. | May 2017 | B2 |
| 9960363 | Eum et al. | May 2018 | B2 |
| 10199580 | Mizutani et al. | Feb 2019 | B2 |
| 10916709 | Eum | Feb 2021 | B2 |
| 10964892 | Huh | Mar 2021 | B2 |
| 20070190355 | Ikeda et al. | Aug 2007 | A1 |
| 20100039026 | Yang et al. | Feb 2010 | A1 |
| 20120126217 | Yoshida et al. | May 2012 | A1 |
| 20120214993 | Aihara et al. | Aug 2012 | A1 |
| 20140001456 | Mizutani et al. | Jan 2014 | A1 |
| 20140054561 | Nam et al. | Feb 2014 | A1 |
| 20140073784 | Mizutani et al. | Mar 2014 | A1 |
| 20140100367 | Yoon et al. | Apr 2014 | A1 |
| 20140367654 | Kim et al. | Dec 2014 | A1 |
| 20150236273 | Jang et al. | Aug 2015 | A1 |
| 20150243897 | Montenegro et al. | Aug 2015 | A1 |
| 20150340622 | Inoue et al. | Nov 2015 | A1 |
| 20160028021 | Zeng et al. | Jan 2016 | A1 |
| 20160056388 | Oka et al. | Feb 2016 | A1 |
| 20160072073 | Lee et al. | Mar 2016 | A1 |
| 20160111655 | Mizutani et al. | Apr 2016 | A1 |
| 20160308147 | Parham et al. | Oct 2016 | A1 |
| 20170033294 | Jang et al. | Feb 2017 | A1 |
| 20170098777 | Huh et al. | Apr 2017 | A1 |
| 20170104163 | Lee et al. | Apr 2017 | A1 |
| 20170186965 | Parham et al. | Jun 2017 | A1 |
| 20180175302 | Jang et al. | Jun 2018 | A1 |
| Number | Date | Country |
|---|---|---|
| 1867646 | Nov 2006 | CN |
| 101381601 | Mar 2009 | CN |
| 102372665 | Mar 2012 | CN |
| 102574813 | Jul 2012 | CN |
| 103380508 | Oct 2013 | CN |
| 104073241 | Oct 2014 | CN |
| 106132937 | Nov 2016 | CN |
| 106471093 | Mar 2017 | CN |
| 2 752 902 | Jul 2014 | EP |
| 3 127 901 | Feb 2017 | EP |
| 3 127 988 | Feb 2017 | EP |
| 2004002297 | Jan 2004 | JP |
| 2008-110968 | May 2008 | JP |
| 2008-156316 | Jul 2008 | JP |
| 2009-170814 | Jul 2009 | JP |
| 2009-275030 | Nov 2009 | JP |
| 2012-62450 | Mar 2012 | JP |
| 2012522042 | Sep 2012 | JP |
| 2014514344 | Jun 2014 | JP |
| 2014-125449 | Jul 2014 | JP |
| 2014-183315 | Sep 2014 | JP |
| 2016-724 | Jan 2016 | JP |
| 2016019002 | Feb 2016 | JP |
| 2018506847 | Mar 2018 | JP |
| 2018-531883 | Nov 2018 | JP |
| 1020100112903 | Oct 2010 | KR |
| 10-2011-0008892 | Jan 2011 | KR |
| 1020110112186 | Oct 2011 | KR |
| 10-2012-0044523 | May 2012 | KR |
| 10-2012-0046778 | May 2012 | KR |
| 10-2012-0052231 | May 2012 | KR |
| 10-2012-0132815 | Dec 2012 | KR |
| 1020130094903 | Aug 2013 | KR |
| 10-2013-0135178 | Dec 2013 | KR |
| 10-2014-0014959 | Feb 2014 | KR |
| 10-2014-0030786 | Mar 2014 | KR |
| 1020140046541 | Apr 2014 | KR |
| 10-2014-0101661 | Aug 2014 | KR |
| 10-2015-0002072 | Jan 2015 | KR |
| 10-2015-0041652 | Apr 2015 | KR |
| 10-1542714 | Aug 2015 | KR |
| 10-2015-0115622 | Oct 2015 | KR |
| 10-2015-0115648 | Oct 2015 | KR |
| 10-2015-0135097 | Dec 2015 | KR |
| 10-2016-0011036 | Jan 2016 | KR |
| 10-2016-0106217 | Sep 2016 | KR |
| 10-1737298 | May 2017 | KR |
| 10-1745799 | Jun 2017 | KR |
| 2004039786 | May 2004 | WO |
| 2010072300 | Jul 2010 | WO |
| 2011010843 | Jan 2011 | WO |
| 2011021689 | Feb 2011 | WO |
| 2011046182 | Apr 2011 | WO |
| 2012157537 | Nov 2012 | WO |
| 2013077352 | May 2013 | WO |
| 2013122402 | Aug 2013 | WO |
| 2014023388 | Feb 2014 | WO |
| 2014054912 | Apr 2014 | WO |
| 2014171541 | Oct 2014 | WO |
| 2014185751 | Nov 2014 | WO |
| 2014200148 | Dec 2014 | WO |
| 2015005559 | Jan 2015 | WO |
| 2015041358 | Mar 2015 | WO |
| 2015090504 | Jun 2015 | WO |
| 2015152634 | Oct 2015 | WO |
| 2015152633 | Oct 2015 | WO |
| 2015152650 | Oct 2015 | WO |
| 2015169412 | Nov 2015 | WO |
| 2016076384 | May 2016 | WO |
| 2016111515 | Jul 2016 | WO |
| Entry |
|---|
| Zhong et al., Journal of Physical Chemistry C, (2011), vol. 115, pp. 2423-2427. (Year: 2011). |
| Chen et al., Journal of Materials Chemistry, (2009), vol. 19, pp. 8112-8118. (Year: 2009). |
| Reghu, R. R., & Grazulevicius, J. V. (2016). Dendritic Organic Semiconductors Based on Pyrene and Triazine Derivatives. Advanced Polymeric Materials: From Macro-to Nano-Length Scales, 31. (Year: 2016). |
| Kukhta, N. A., Simokaitiene, J., Volyniuk, D., Ostrauskaite, J., Grazulevicius, J. V., Juska, G., & Jankauskas, V. (2014). Effect of linking topology on the properties of star-shaped derivatives of triazine and fluorene. Synthetic metals, 195, 266-275. (Year: 2014). |
| Data, P., Zassowski, P., Lapkowski, M., Grazulevicius, J.V., Kukhta, N.A. and Reghu, R.R., 2016. Electrochromic behaviour of triazine based ambipolar compounds. Electrochimica Acta, 192, pp. 283-295. (Year: 2016). |
| International Search Report of PCT/KR2015/014222, dated Aug. 12, 2016. [PCT/ISA/210]. |
| Korean Intellectual Property Office, Communication dated Jul. 31, 2017, issued in Korean Application No. 10-2017-0015045. |
| Korean Intellectual Property Office, Communication dated Nov. 21, 2016, issued in Korean Application No. 10-2015-0171639. |
| Japanese Patent Office; Communication dated Jul. 3, 2018 in counterpart application No. 2017-534340. |
| Japanese Patent Office; Communication dated Jul. 20, 2018 in counterpart application No. 2017-534328. |
| European Patent Office; Communication dated Sep. 4, 2018 in counterpart application No. 15873577.9. |
| Oyama, T., et al., “Electron-Transporting Materials Containing Pyridylphenyl groups and Their Application to Organic Light-Emitting Devices”, Journal of Photopolymer Science and Technology, vol. 23, No. 3, 2010, pp. 2-9/E (8 pages). |
| Hongliang Zhong et al., “New Conjugated Triazine Based Molecular Materials for Application in Optoelectronic Devices: Design, Synthesis, and Properties”, The Journal of Physical Chemistry, vol. 115, No. 5, pp. 2423-2427, 5 pages, YEAR: 2011. |
| Chris S. K. Mak et al., “Singlet and Triplet Emission from Polymers for OLED Applications”, Proceedings of SPIE vol. 5519, 2004, pp. 24-33, 12 pages. |
| The State Intellectual Property Office of People's Republic of China; Communication dated Mar. 13, 2019 in Chinese Application No. 201580069761.5. |
| Japanese Patent Office; Communication dated Feb. 12, 2019 in counterpart application No. 2017-534340. |
| European Patent Office; Communication dated Mar. 28, 2019 in counterpart European Application No. 15873577.9. |
| Japanese Patent Office; Communication dated Mar. 12, 2019 in counterpart application No. 2017-534328. |
| Machine translation for KR 10-2015-0002072 (publication date: Jan. 2015). (Year: 2015). |
| Number | Date | Country | |
|---|---|---|---|
| 20200185617 A1 | Jun 2020 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15539223 | US | |
| Child | 16795199 | US |
